Repaglinide 1.0 Mg Tablets
Out of date information, search anotherPackage leaflet: Information for the user
REPAGLINIDE 0.5 mg TABLETS
REPAGLINIDE 1 mg TABLETs
REPAGLINIDE 2 mg TABLETs
(repaglinide)
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
• Keep this leaflet. You may need to read it again.
• If you have any further questions, ask your doctor or pharmacist.
• This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
• If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.
What is in this leaflet:
1. What Repaglinide is and what it is used for
2. What you need to know before you take Repaglinde
3. How to take Repaglinide
4. Possible side effects
5. How to store Repaglinide
6. Contents of pack and other information
1. WHAT REPAGLINIDE IS AND WHAT IT IS USED FOR
Repaglinide is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin and thereby lower your blood sugar (glucose).
Type 2 diabetes is a disease in which your pancreas does not make enough insulin to control the sugar or where your body does not respond normally to the insulin it produces.
Repaglinide is used to control type 2 diabetes in adults as an add-on to diet and exercise: treatment is usually started if diet, exercise and weight reduction alone have not been able to control (or lower) your blood sugar. Repaglinide can also be given with metformin, another medicine for diabetes.
Repaglinide has been shown to lower the blood sugar, which helps to prevent complications from your diabetes.
2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE REPAGLINIDE
Do not take Repaglinide
• If you are hypersensitive (allergic) to repaglinide or any of the other ingredients in this medicine (listed in section 6).
• If you have type 1 diabetes
• If the acid level in your body is raised (diabetic ketoacidosis)
• If you have a severe liver disease
• If you take gemfibrozil (a medicine used to lower increased fat levels in the blood).
Warning and precautions
Talk to your doctor before taking Repaglinide:
• If you have liver problems. Repaglinide is not recommended in patients with moderate liver disease. Repaglinide should not be taken if you have a severe liver disease (see Do not take Repaglinide).
• If you have kidney problems. Repaglinide should be taken with caution.
• If you are about to have major surgery or you have recently suffered a severe illness or infection. At such times diabetic control may be lost.
• If you are under 18 or over 75 years of age. Repaglinide is not recommended. It has not been studied in these age groups.
Talk to your doctor if any of the above applies to you. Repaglinide may not be suitable for you. Your doctor will advise you.
Children and adolescents
Do not take this medicine if you are under 18 years of age.
If you get a hypo (low blood sugar)
You may get a hypo (short for hypoglycaemia) if your blood sugar gets too low. This may happen:
• If you take too much Repaglinide
• If you exercise more than usual
• If you take other medicines or suffer from liver or kidney problems (see other sections of 2.What you need to know before you take Repaglinide).
The warning signs of a hypo may come on suddenly and can include: cold sweat; cool pale skin; headache; rapid heart beat; feeling sick; feeling very hungry; temporary changes in vision; drowsiness; unusual tiredness and weakness; nervousness or tremor; feeling anxious; feeling confused; difficulty in concentrating.
If your blood sugar is low or you feel a hypo coming on: eat glucose tablets or a high sugar snack or drink, then rest.
~CQ'
When symptoms of hypoglycaemia have disappeared or when blood sugar levels are stabilised continue Repaglinide treatment.
Tell people you have diabetes and that if you pass out (become unconscious) due to a hypo, they must turn you on your side and get medical help straight away. They must not give you any food or drink. It could choke you.
• If severe hypoglycaemia is not treated, it can cause brain damage (temporary or permanent) and even death.
• If you have a hypo that makes you pass out, or a lot of hypos, talk to your doctor. The amount of Repaglinide, food or exercise may need to be adjusted.
If your blood sugar gets too high
Your blood sugar may get too high (hyperglycaemia).
This may happen:
• If you take too little Repaglinide
• If you have an infection or a fever
• If you eat more than usual
• If you exercise less than usual.
The warning signs of too high blood sugar appear gradually. They include: increased urination; feeling thirsty; dry skin and dry mouth. Talk to your doctor. The amount of Repaglinide, food or exercise may need to be adjusted.
Other medicines and Repaglinide
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
You can take Repaglinide with metformin, another medicine for diabetes, if your doctor prescribes it.
If you take gemfibrozil (used to lower increased fat levels in the blood) you should not take Repaglinide.
Your body's response to Repaglinide may change if you take other medicines, especially these:
• Monoamine oxidase inhibitors (MAOI) used to treat depression
• Beta blockers (used to treat high blood pressure or heart conditions)
• ACEinhibitors (used to treat heart conditions)
• Salicylates (e.g. aspirin)
• Octreotide (used to treat cancer)
• Nonsteroidal anti-inflammatory drugs (NSAID) (a type of painkillers)
• Steroids (anabolic steroids and corticosteroids -used for anemia or to treat inflammation)
• Oral contraceptives (birth control pills)
• Thiazides (diuretics or 'water pills')
• Danazol (used to treat breast cysts and endometriosis)
• Thyroid products (used to treat low levels of thyroid hormones)
• Sympathomimetics (used to treat asthma)
• Clarithromycin, trimethoprim, rifampicin (antibiotic medicines)
• Itraconazole, ketoconazole (antifungal medicines)
• Gemfibrozil (used to treat high blood fats)
• Ciclosporin (used to suppress the immune system)
• Deferasirox (used to reduce chronic iron overload)
w
|
Description |
Repaglinide 0.5/1/2mg 30/90 |
No. of colours |
Page Count | ||
|
Component Type |
Leaflet |
Pharma Code |
TBC |
Colours |
Black |
|
Affiliate Item Code |
513255 |
SAP No. |
N/A | ||
|
Non-Print Colours | |||||
|
Superceded Affiliate Item Code |
372177 |
Vendor Job No. |
223877 | ||
|
TrackWise PR No. |
513255 |
Proof No. |
1 |
Equate CMYK | |
|
MA No. |
17277/0054, 0055 & 0056 |
Client Market |
fn,uk,gb,sweden, lux,eS,it,romaniA, de,Fr,BeL |
with | |
|
Packing Site/Printer |
Komarom |
Keyline/DrawingNo] |
N/A |
Main Font |
Myriad Pro Body Text Size 9.5 pt |
|
Supplier Code |
TBC |
Barcode Info |
N/A |
Dimensions |
170 x 360mm |
|
Sign-offs | |||||
• Phenytoin, carbamazepine, phenobarbital (used to treat epilepsy)
• St. John's wort (herbal medicine).
Repaglinide with alcohol
Alcohol can change the ability of Repaglinide to reduce the blood sugar. Watch for signs of hypo.
Pregnancy and breast-feeding
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine.
You should not take Repaglinide if you are pregnant or you are planning to become pregnant.
You should not take Repaglinide if you are breast-feeding.
Driving and using machines
Your ability to drive or use a machine may be affected if your blood sugar is low or high. Bear in mind that you could endanger yourself or others. Please ask your doctor whether you can drive a car if you:
• Have frequent hypos
• Have few or no warning signs of hypos.
3. HOW TO TAKE REPAGLINIDE
Always take this medicine exactly as your doctor has told you. Check with your doctor if you are not sure. Your doctor will work out your dose.
• The normal starting dose is 0.5 mg before each main meal. Swallow the tablets with a glass of water immediately before or up to 30 minutes before each main meal.
• The dose may be adjusted by your doctor by up to 4 mg to be taken immediately before or up to 30 minutes before each main meal. The maximum recommended daily dose is 16 mg.
Do not take more Repaglinide than your doctor has recommended.
If you take more Repaglinide than you should
If you take too many tablets, your blood sugar may become too low, leading to a hypo. Please see If you get a hypo on what a hypo is and how to treat it.
If you forget to take Repaglinide
If you miss a dose, take the next dose as usual - do not double the dose.
If you stop taking Repaglinide
Be aware that the desired effect is not achieved if you stop taking Repaglinide. Your diabetes may get worse. If any change of your treatment is necessary contact your doctor first.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
4. POSSIBLE SIDE EFFECTS
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Hypoglycaemia
The most frequent side effect is hypoglycaemia which may affect up to 1 in 10 patients (see If you get a hypo in section 2). Hypoglycaemic reactions are generally mild/moderate but may occasionally develop into hypoglycaemic unconsciousness or coma. If this happens, contact medical assistance immediately.
Allergy
Allergy is very rare (may affect up to 1 in 10,000 patients). Symptoms such as swelling, difficulty in breathing, rapid heartbeat, feeling dizzy and sweating could be signs of anaphylactic reaction. Contact a doctor immediately.
Other side effects
Common (may affect up to 1 in 10 patients)
• Stomach pain
• Diarrhoea
Rare (may affect up to 1 in 1000 patients)
• Acute coronary syndrome (but it may not be due to the medicine)
Very rare (may affect up to 1 in 10,000 patients)
• Vomiting
• Constipation
• Visual disturbances
• Severe liver problems, abnormal liver function, increased liver enzymes in your blood.
Frequency not known
• Hypoglycaemic coma or unconsciousness (very severe hypoglycaemic reactions - see If you get a hypo). Contact a doctor immediately
• Hypersensitivity (such as rash, itchy skin, reddening of the skin, swelling of the skin)
• Feeling sick (nausea).
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard By reporting side effects you can help provide more information on the safety of this medicine.
5. HOW TO STORE REPAGLINIDE
Keep this medicine out of the sight and reach of children.
This product does not need any special storage conditions
Do not use this medicine after the expiry date which is stated on the carton and the blister foil after 'EXP'. The expiry date refers to the last date of that month.
Do not throw away medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
6. CONTENTS OF THE PACK AND OTHER INFORMATION
What Repaglinide contains
The active substance is repaglinide.
The other ingredients are:
Microcrystalline cellulose (E460), calcium hydrogen phosphate anhydrous, maize starch, amberlite (polacrilin potassium), poloxamer 407, meglumine, glycerol, Povidone and silica, colloidal anhydrous, magnesium stearate, iron oxide yellow (E172) only in the 1 mg tablets and iron oxide red (E172) only in the 2 mg tablets.
What Repaglinide looks like and contents of the pack
Repaglinide tablets are round and biconvex.
0.5 mg tablets are white, 1 mg tablets are yellow, mottled and 2 mg tablets are pink, mottled.
Repaglinide are available in blister packs of 30 or 90 tablets.
Not all pack size may be marketed.
Marketing authorisation holder and manufacturer
Marketing Authorisation Holder and Manufacturer Pharmathen S.A., Dervenakion 6, 15351 Pallini, Attiki, Greece
Alternative Manufacturer
Pharmathen International S.A
Industrial Park Sapes Rodopi Perfecture, Block 5,
Rodopi 69300, Greece
Mylan Hungary Kft, H-2900 Komarom,
Mylan utca 1, Hungary
This leaflet was last revised in 10/2014 513255
m
|
Description |
Repaglinide 0.5/1/2mg 30/90 |
No. of colours |
Page Count | ||
|
Component Type |
Leaflet |
Pharma Code |
TBC |
Colours |
Black |
|
Affiliate Item Code |
513255 |
SAP No. |
N/A | ||
|
Non-Print Colours | |||||
|
Superceded Affiliate Item Code |
372177 |
Vendor Job No. |
223877 | ||
|
TrackWise PR No. |
513255 |
Proof No. |
1 |
Equate CMYK | |
|
MA No. |
17277/0054, 0055 & 0056 |
Client Market |
fn,uk,gb,sweden, lux,eS,it,romaniA, de,Fr,BeL |
with | |
|
Packing Site/Printer |
Komarom |
Keyline/DrawingNo] |
N/A |
Main Font |
Myriad Pro Body Text Size 9.5 pt |
|
Supplier Code |
TBC |
Barcode Info |
N/A |
Dimensions |
170 x 360mm |
|
Sign-offs | |||||